The US Food and Drug Administration has rejected a company's application to market a tiny camera that can film inside a person's brain, the New York Times reports.
The device, called Neuralink, is designed to show doctors what parts of a person's brain are affected by diseases such as Alzheimer's, Parkinson's, and multiple sclerosis.
But the FDA says the camera doesn't meet its standards for "exceptionally effective" treatment, and the company won't be allowed to sell its product until it can show that it can get the OK from the agency's Center for Devices and Radiological Health.
A person's brain can be damaged by everything from Alzheimer's and Parkinson's to schizophrenia and autism, the Times notes.
In the case of Neuralink, it's designed to show doctors what parts of a person's brain are affected by diseases such as Alzheimer's and multiple sclerosis, according to a press release.
The company raised $55 million in a recent round of financing, Top Health News reports.
Read the Entire Article
A customized collection of news from foundations from around the Web.
HootSuite CEO Ryan Holmes says “…social tools are getting more broadly adopted across organizations. It’s not just marketing anymore, it’s sales, public relations, human relations, everywhere.”